Cytoskeleton-associated protein 2 is a potential predictive marker for risk of early and extensive recurrence of hepatocellular carcinoma after operative resection
Abstract
No abstract availableKeywords
This publication has 24 references indexed in Scilit:
- Liver Transplantation for Hepatocellular Carcinoma: Lessons Learned and Future DirectionsClinics in Liver Disease, 2011
- Specific primary sequence requirements for Aurora B kinase-mediated phosphorylation and subcellular localization of TMAP during mitosisCell Cycle, 2010
- Salvage transplantation for stage IVa hepatocellular carcinoma, what are the guidelines?Clinical Transplantation, 2009
- TMAP/CKAP2 is essential for proper chromosome segregationCell Cycle, 2009
- Hepatocellular carcinoma developed on compensated cirrhosis: Resection as a selection tool for liver transplantationLiver Transplantation, 2008
- Aurora kinase B is a predictive factor for the aggressive recurrence of hepatocellular carcinoma after curative hepatectomyBritish Journal of Surgery, 2008
- Development of sorafenib and other molecularly targeted agents in hepatocellular carcinomaCancer, 2007
- Functional Importance of the Anaphase-Promoting Complex-Cdh1-Mediated Degradation of TMAP/CKAP2 in Regulation of Spindle Function and CytokinesisMolecular and Cellular Biology, 2007
- Up-regulation of cytoskeletal-associated protein 2 in primary human gastric adenocarcinomasJournal of Cancer Research and Clinical Oncology, 2003
- Identification of a novel cDNA, encoding a cytoskeletal associated protein, differentially expressed in diffuse large B cell lymphomasOncogene, 1998